Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthma

scientific article

Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1124/JPET.111.186379
P698PubMed publication ID22160268
P5875ResearchGate publication ID51870131

P50authorClive PageQ29643391
Luigino CalzettaQ51502964
P2093author name stringMario Cazzola
James D Clark
William M Abraham
Sheena Patel
Maria G Matera
Wai L Liu
Hinnah Campwala
Michael Yeadon
Peter T Peachell
Philip A Clarke
Cara M Williams
Nicholas P Clarke
Christopher A Hewson
Suzanne Havard
Emma Luscombe
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectasthmaQ35869
P304page(s)656-665
P577publication date2011-12-07
P1433published inJournal of Pharmacology and Experimental TherapeuticsQ1500272
P1476titlePreclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthma
P478volume340

Reverse relations

cites work (P2860)
Q41292274C2 domain membrane penetration by group IVA cytosolic phospholipase A₂ induces membrane curvature changes
Q35175554Cytosolic phospholipase A2α is critical for angiotensin II-induced hypertension and associated cardiovascular pathophysiology
Q36404328Dietary Compound Kaempferol Inhibits Airway Thickening Induced by Allergic Reaction in a Bovine Serum Albumin-Induced Model of Asthma
Q38975723Inhibitors of phospholipase A2 and their therapeutic potential: an update on patents (2012-2016).
Q37583613Low molecular weight hyaluronan activates cytosolic phospholipase A2α and eicosanoid production in monocytes and macrophages.
Q58570548Modeling Membrane Curvature Generation due to Membrane⁻Protein Interactions
Q40059650Neutrophil-Derived Cytosolic PLA2α Contributes to Bacterial-Induced Neutrophil Transepithelial Migration.
Q28534706Phospholipase A2 in experimental allergic bronchitis: a lesson from mouse and rat models
Q38072094Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010--present).
Q37679681Respiratory allergies: a general overview of remedies, delivery systems, and the need to progress
Q92578273Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2
Q92127138The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders
Q37191456The involvement of phospholipases A2 in asthma and chronic obstructive pulmonary disease
Q36744081The molecular basis of ceramide-1-phosphate recognition by C2 domains.

Search more.